期刊文献+

白细胞介素1β对人肾小球系膜细胞LOX-1和ABCA1表达的影响

Impact of interleukin 1β on the expression of lectin-like oxidized LDL receptor 1 and ABCA1 in human mesangial cell line
原文传递
导出
摘要 目的研究白细胞介素1β(IL-1β)对人肾小球系膜细胞株(HMCL)植物血凝素样氧化低密度脂蛋白受体1(LOX-1)以及腺苷三磷酸结合盒转运体A1(ABCA1)表达的影响,及其与细胞胆同醇稳态的关系。方法实时定量PCR和Western印迹法检测IL-1β对人肾小球系膜细胞LOX-1、ABCA1表达的影响。结果人肾小球系膜细胞表达LOX-1mRNA和蛋白。IL-1β促进人肾小球系膜细胞LOX-1mRNA和蛋向表达,5μg/LIL-1β刺激细胞0~24h,LOX—1 mRNA表达于6h达高峰,为对照的6.87倍;LOX-1蛋-24h达高峰,为对照的1.88倍。IL-1β降低脂质负荷的人肾小球系膜细胞ABCA1 mRNA和蛋闩表达。5μg/LIL-1β刺激细胞0~48h,48h时ABCA1 mRNA和蛋向下降最明显,分别为对照的19.0%和50.62%。结论IL-1β促进人肾小球系膜细胞LOX-1表达,抑制ABCAI的表达,导致细胞内胆同醇的失衡,促使其变成泡沫细胞,可能加重肾小球硬化和肾病的进展。 Objective To observe the impact of IL-1β on the expression of lecfin-like oxidized LDL receptor 1 (LOX-1) and ATP-binding cassette transporter A1 (ABCAI) in human mesangial cell line (HMCL), and its association with cholesterol homeostasis of HMCL. Methods Levels of LOX-1 and ABCA1 of HMCL induced by IL-1β were examined by using real-time PCR and Western blot. Results IL-1β up-regulated LOX-1 mRNA and protein expression. Treated with 5 μg/L IL-1β, the levels of LOX-1 mRNA and protein reached the peak after 6 h and 24 h of stimulation and were 6.87 folds and 1.88 folds of control rspectively. The expression of ABCA1 mRNA and protein of lipid-loaded HMCL was down-regulated by IL-1β. Stimulated with 5 μg/L IL-1β, the expression of ABCA1 mRNA and protein decreased to the lowest level, 19.0% and 50.62% of the baseline respectively. Conclusions The expression of LOX-1 can be up- regulated while the expression of ABCA1 can be decreased by the stimulation of IL-1β. IL-1β can enhance dyslipidemia and influence the balance of cholesterol homeostasis of HMCL.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2008年第10期725-729,共5页 Chinese Journal of Nephrology
关键词 白细胞介素1 受体 LDL 胆网醇 系膜细胞 植物血凝素样 氧化低密度脂蛋门受体 腺苷三磷酸结合盒转运体A1 Interleukin 1 Receptors, LDL Cholesterol Mesangial cell Lectin-like oxidized LDL receptor 1 ATP-binding cassette transporter A1
  • 相关文献

参考文献14

  • 1Moorhead JF. Chan MK, El-Nahas M, et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo- interstitial disease. Lancet, 1982, 2 (8311): 1309-1311.
  • 2Moorhead JF, Brunton C, Varghesc Z. Glnmerular atherosclerosis. Miner Electrolyte Metab, 1997, 23: 287-290.
  • 3Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340: 115-126.
  • 4Wanner C, Zimmermann J, Schwedler S, et al. Inflammation and cardiovascular risk in dialysis patients. Kidncy Int Suppl, 2002, 80: S99-S102.
  • 5Kakutani M, Ueda M, Naruko T, et al. Accumulation of LOX-1 ligand in plasma and atherosclerotic: lesions of watanabe heritable hyperlipidemic rabbits: Identification by a novel enzyme immnnoasay. Biochem Biophys Res Commun, 2001, 282: 180-185.
  • 6Oram JF. HDL apolipoproteins and ABCA I partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol, 2003, 23: 720-727.
  • 7Ruan XZ, Varghese Z, Powis SH, et al. Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney lnt, 2001, 60: 1716-1725.
  • 8Ruan XZ, Varghese Z, Moorhead JF, et al. Inflammation modifies lipid-mediated renal injury. Nephrol Dial Transplant, 2003, 18:27-32.
  • 9Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature, 1997, 386 (6620): 73-77.
  • 10Ruan XZ, Varghese Z, Powis SH, et al. Human mesangial cells express inducible macrophage scavenger receptor. Kidney Int, 1999, 56: 440-451.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部